180 THERAPEUTICS LP

Patent Applications and Registrations

Patent applications and USPTO patent grants for 180 THERAPEUTICS LP.The latest application filed is for "method of treating dupuytren's disease using a pre-filled syringe".

Company Profile

8.3.14

180 THERAPEUTICS LP - Cambridge MA
180 Therapeutics LP - Sudbury MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of treating a localized fibrotic disorder using an IL-33 antagonist Grant 11,400,154 - Larsen , et al. August 2, 2	2022-08-02
Method of Treating Dupuytren's Disease Using A Pre-filled Syringe App 20220235125 - Nanchahal; Jagdeep ; et al.	2022-07-28
Method Of Treating A Localized Fibrotic Disorder Using A Tnf Receptor 2 Antagonist App 20210386855 - Larsen; Glenn ; et al.	2021-12-16
Method Of Treating Early Stage Dupuytren's Disease App 20210040196 - NANCHAHAL; Jagdeep ; et al.	2021-02-11
Method Of Treating A Localized Fibrotic Disorder Using An Il-33 Antagonist App 20200338193 - Larsen; Glenn ; et al.	2020-10-29
Method of treating a localized fibrotic disorder using an IL-33 antagonist Grant 10,500,273 - Larsen , et al. Dec	2019-12-10
Method Of Treating Localized Fibrotic Disorders Using An Il-33/tnf Bispecific Antibody App 20190225682 - Nanchahal; Jagdeep ; et al.	2019-07-25
Method Of Treating Systemic Fibrotic Disorders Using An Il-33/tnf Bispecific Antibody App 20190202907 - Nanchahal; Jagdeep ; et al.	2019-07-04
Method Of Treating A Localized Fibrotic Disorder Using A Tnf Receptor 2 Antagonist App 20180036404 - Larsen; Glenn ; et al.	2018-02-08
Method Of Treating A Localized Fibrotic Disorder Using An Il-33 Antagonist App 20180030130 - Larsen; Glenn ; et al.	2018-02-01
Method Of Treating Fibroproliferative Disorders Including Dupuytren's Disease With One Or More Specific Human Matrix Metalloproteinase And A Tnf Antagonist App 20160158325 - Larsen; Glenn	2016-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.